BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       
BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login
search help
Search Results
Documents 1-2 out of 2 found
  Current Search:  nasacort: 2     
HTML
100%
BARR PHARMACEUTICALS INC EPS Estimated At 2.78: Current Recommendation is Buy
Company: BARR PHARMACEUTICALS INC Report Headline: 'BRL: Potential Nasacort Settlement' Report Date: June 09, 2008 Current FY EPS Estimate [FY2008]: 2.78 Previous EPS Estimate for Current FY [FY2008]: 2.78 Current Quarter EPS Estimate ...
Calibre Macro World:  Jun 11 2008 7:36PM
Matching: nasacort 		Find similar documents
HTML
100%
BARR PHARMACEUTICALS INC EPS Estimated At 2.78: Current Recommendation is Buy
Company: BARR PHARMACEUTICALS INC Report Headline: 'BRL: Potential Nasacort Settlement' Report Date: June 09, 2008 Current FY EPS Estimate [FY2008]: 2.78 Previous EPS Estimate for Current FY [FY2008]: 2.78 Current Quarter EPS Estimate ...
Macro World Investor:  Jun 11 2008 7:18PM
Matching: nasacort 		Find similar documents
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.